FDA Approved: ILLUCCIX — Supplemental Application (Telix Pharmaceuticals (US) Inc.)

View source ↗

Summary

FDA approved a supplemental application for ILLUCCIX, a kit for preparing Gallium-68 gozetotide injection used in PET imaging of neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• ILLUCCIX (Kit for the preparation of gallium Ga-68 gozetotide injection)

Snippet

SUPPL AP for ILLUCCIX (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE INJECTION)